Best Life Sciences Platforms and Tools Companies in Italy
The 97 best Life Sciences Platforms and Tools companies in Italy in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Silicon Biosystems.
Italy's Life Sciences Platforms and Tools sector gets a proper ranking here, 97 companies tracked and sorted by disclosed equity funding and recent momentum, so you can cut straight to who's actually capitalized. Total disclosed funding sits at $87M across the cohort. No unicorns yet, but Silicon Biosystems leads at $26M raised, Sibylla Biotech follows at $25M, and Comecer has pulled in $11M, which tells you where the serious bets are landing. Europa, EIC Fund, and EIT Health are the most active backers, a pattern that signals heavy reliance on European public capital rather than private venture. That's not a knock, it's just the structural reality shaping the field right now.
The global market these companies are pitching into was valued at roughly $89.4B in 2020 and is forecast to hit $183.8B by 2027 at a 10.8% CAGR, driven by gains in quantitative accuracy, mass spectrometry resolution, and information sciences. I'd watch the regulatory friction closely though, because compliance overhead tends to compress timelines for smaller platforms in ways that favor better-funded players. If you're benchmarking Italian operators against that global curve, the funding gap to names like Merck KGaA or Illumina is real, and the $87M total here reflects an early-stage ecosystem still finding its footing.
- ResearchAndMarkets.com
- Precedence Research
Our analysis of 50 Life Sciences Platforms and Tools companies
$4.8b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences Platforms and Tools companies in Italy
| # | Company | Disclosed funding | Last round | Stage | Founder | Employees | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Silicon Biosystems Developer of lab on a chip technologies for miniaturized cell-biology testing | $26M | 196 mo ago | Acquired | — | 17,000 | DNNMicrosoft ASP.NETBootstrap+15 | 566 patents Advanced genomic amplification and single‑cell diagnostics for disease monitoring and prenatal testing | — |
| 2 | Sibylla Biotech AI-powered platform for drug discovery | $25M | 44 mo ago | Series A | Lidia Pieri Co-Founder & CEO | 14 | WordPressApple iCloud MailGoogle Workspace+16 | 3 patents Patents concentrated in computing, sensing & instrumentation | — |
| 3 | Comecer Protective equipment and containment systems for nuclear medicine, nuclear power plants and aseptic… | $11M | 127 mo ago | Acquired | Alessia Zanelli CEO | 4 | WordPressMySQLPHP+26 | — | 2 launchs |
| 4 | Cellply Developer of in-vitro diagnostic products for the detection of cancer | $8M | 1 mo ago | Series B | Roberto Guerrieri Co-Founder | 28 | Node.jsVimeoTailwind CSS+15 | 43 patents Cell therapy product characterization and in‑vitro solid‑tumor activity screening | 1 partnership |
| 5 | Personal Genomics Developer of fermentation technology to convert methane and carbon dioxide into useful chemicals | $2M | 49 mo ago | Acquired | Johnsee Lee Founder & CEO | — | WordPressMySQLPHP+24 | 4 patents Targeted nucleic acid detection and genomic region enrichment kit technologies | — |
| 6 | Polo Genomica Genetica e Biologia Provider of products and services in the field of genomics, genetics , bioinformatics, and biology | $2M | 52 mo ago | Funding Raised | Greta Immobile Molaro CEO | — | WordPress Block EditorwpBakeryElementor+32 | 8 patents Molecular diagnostics for low-frequency variants and anti‑CRISPR gene‑drive control technologies. | — |
| 7 | Allelica Provider of genomic DNA tests for assessing predisposition to diseases & personalized nutrition | $2M | 63 mo ago | Seed | Giordano Botta Co-Founder & CEO | 13 | ContentfulNode.jsSalesforce+16 | 13 patents Computational genomics data imputation and predictive health prognosis for menopause and cardiovascular disease | — |
| 8 | Abiel Develop, products for the lysis of the extracellular matrix. | $1M | 77 mo ago | Funding Raised | Giulio Ghersi CEO | — | — | 11 patents Recombinant collagenase enzymes for medical debridement and tissue dissociation | — |
| 9 | Vegea Developer of biomaterial from wine using bioprocess technology | $1M | 81 mo ago | Funding Raised | Gianpiero Tessitore Founder & CEO | — | WordPressMySQLPHP+16 | — | 1 launch |
| 10 | Plasmore Develops nanoplasmon imaging technology | $1M | 65 mo ago | Funding Raised | Andrea Valsesia Co-Founder | — | — | 4 patents Patents concentrated in chemistry & materials | — |
| 11 | Diamante Nanotechnology based tools for diagnostic kits | $996K | 41 mo ago | Seed | Valentina Garonzi CEO | — | — | 2 patents Patents concentrated in health & consumer products | — |
| 12 | Giotto Biotech Provider of buffers, dyes, proteins, and life science services | $895K | 63 mo ago | Funding Raised | Lucia Banci Co-Founder | — | Cart FunctionalityWooCommerceWordPress+21 | — | — |
| 13 | Foresee Biosystems Developer of platforms for prediction of drug and chemical toxicological outcomes | $869K | 50 mo ago | Funding Raised | Michele Dipalo Chairman and Chief Executive Officer | — | — | — | — |
| 14 | Bio Biodegradable biopolymer for a wide range of applications | $817K | 79 mo ago | Deadpooled | Marco Astorri Founder & CEO | 100 | — | 26 patents Microbial production of biodegradable polyesters from sucrose feedstocks and polymer blends | — |
| 15 | BiomimX Provider of organs-on-chip platforms for preclinical studies | $697K | 44 mo ago | Seed | Marco Rasponi Co-Founder | 9 | WordPressMySQLPHP+16 | 3 patents Microfluidic platforms for electrophysiological measurement and stimulation | — |
| 16 | SENSE4MED Developer of smart sensors for various biomedical and environmental applications | $549K | 27 mo ago | Seed | Fabiana Arduini CEO | — | — | 5 patents Miniaturized electrochemical sensors and gas‑flow monitoring for point‑of‑care medical diagnostics | — |
| 17 | Immagina BioTechnology Provider of tools for ribosome profiling | $509K | 39 mo ago | Seed | — | 17 | Cart FunctionalityShopwareZoho+24 | 28 patents Detection and quantification of disease‑associated 3′‑phosphate RNA biomarkers for diagnostics | 1 launch |
| 18 | Genomix4Life Provider of a wide range of genomic services for research purposes | $476K | 73 mo ago | Funding Raised | Angela Cordella Co-Founder | — | WordPressPleskMySQL+21 | — | 1 job opening |
| 19 | PlumeStars Italian biotech working on localized antibiotic drug delivery for lung infections in Cystic Fibrosis patients. | $435K | 79 mo ago | Funding Raised | Ruggero Bettini Co-Founder | — | — | 16 patents Nanoparticle-embedded microparticle powders for drug and diagnostic delivery | — |
| 20 | Takis Provider of preclinical research services, vaccines, monoclonal antibodies, and recombinant proteins | $348K | 79 mo ago | Funding Raised | Luigi Aurisicchio Founder & CEO | — | WordPressMySQLPHP+27 | 19 patents Patents concentrated in chemistry & materials | — |
| 21 | S.A.F.A.N Bioinformatics Provider of chemoinformatic and structural bioinformatics services | $281K | 123 mo ago | Seed | — | 1 | — | — | — |
| 22 | Microbion Provider of services for food, agriculture, biotechnology and pharmaceutical industries | $271K | 45 mo ago | Funding Raised | Antonio Del Casale CEO & Co-Founder | 9 | — | 8 patents Modular extragenic markers for precise microbial strain identification and quantification | — |
| 23 | Cellex Provider of bioreactors for cell cultures and tissue engineering | $237K | 41 mo ago | Funding Raised | Giuseppe Labate CEO | 9 | — | 11 patents Automated cell suspension bioreactors with flow diverters for uniform culture | 1 launch |
| 24 | BMR Genomics Provider for DNA sequencing services | $199K | 103 mo ago | Funding Raised | Barbara Simionati CEO | — | — | — | — |
| 25 | SoftMining Provides multiple services for computationally aided drug discovery and data mining | $199K | 43 mo ago | Funding Raised | Stefano Piotto Co-Founder & CEO | 6 | — | 4 patents Antimicrobial peptide therapeutics and mobile device proximity estimation/interface technologies. | — |
| 26 | ADDAX Biosciences Developer of a non-toxic formalin alternative tissue fixative. | $116K | 28 mo ago | Seed | Gianni Bussolati CEO | — | WordPressMySQLPHP+23 | 15 patents Advanced tissue fixation preserving nucleic acids for histology and molecular diagnostics | — |
| 27 | Stem Sel Cell sorter | $112K | 132 mo ago | Funding Raised | Barbara Roda Founder and CTO | 5 | — | 18 patents Automated optical/laser-based fractionation of solid objects for sorting and separation | — |
Top 12 Life Sciences Platforms and Tools companies in Italy
#1
Series B · Bologna, Emilia Romagna · founded 2013 · 28 employees$8.1Mraised▾
Developer of in-vitro diagnostic products for the detection of cancer. The company has developed ONCOSMART is the first In-Vitro Diagnostic (IVD) system that determines the effectiveness of anticancer drugs for a specific patient, testing live cell response to one or multiple cancer drugs. Additionally, it offers prognostic tests based on the immune profile of hospitalized patients with Coronavirus Disease 19.
- May 2026Series B$8.4M
- Sep 2023Series A$3.8M
- Sep 2022Grant (prize money)$258K
- Dec 2021Seed$2.3M
#2
Series A · Trento, Trentino South Tyrol · founded 2017 · 14 employees$25.2Mraised▾
AI-powered platform for drug discovery. The company's approach, named "Pharmacological protein Inactivation by Folding Intermediates Targeting" (PPI-FIT), allows them to identify and develop small molecules acting on targets involved in different types of diseases. It's pipeline currently focuses on Cyclin D1 and KRAS as the main targets for oncology and inflammatory diseases.
- Oct 2022Series A$22.5M
- Oct 2019Seed$2.6M
#3
Acquired · Bologna, Emilia Romagna · founded 1999 · 17000 employees$25.5Mraised▾
Developer of lab on a chip technologies for miniaturized cell-biology testing. It offers Ampli1 whole genome amplification (WGA) kit for amplification of DNA content of a single cell and DEPArray technology that helps to trap cells in dielectrophoresis. It also provides DEPArray system, an automated instrument that helps to identify, quantify, and recover individual rare cells and Cell Browser, a software solution that enables image-based selection and recovery of specific cells and cell populations in a sample.
- Feb 2010Series C$16M
- Mar 2007Series A$6.8M
- Jan 2007Unattributed$2.7M
#4
Acquired · Castel Bolognese, Emilia Romagna · founded 1974 · 4 employees$10.6Mraised▾
Comecer designs and manufactures high-technology protective and containment systems for application in nuclear medicine (hot cells, shielded and robotic radiopharmaceuticals dispensing and isolation systems, shielded laminar flow systems), aseptic manufacturing (sterility testing isolator, batch vial filling system, isolated dispensing and weighing systems, mini plants, isolators for fill-finish manufacturing and containment, automated and manual compounding systems, glove integrity testing systems, restricted access barrier systems for crimping machines, modular cell culture isolators, advanced incubator systems for cell therapy applications, and high-performance components) and nuclear power plant components (shielded bunker penetrations, shielded transport containers, shielded waste trolleys, whole body counters, bunker doors, shielded cell for sampling of radioactive waste). The company also offers integrated services through the so-called 1MP (One Manufacturer Practices), where a team of specialists assists customers in building and managing new production centers or PET labs with full GMP compliance, supporting all the operations and validations to obtain the GMP production l
#5
Seed · Rome, Lazio · founded 2019$549.1Kraised▾
Developer of smart sensors for various biomedical and environmental applications. The company offer a range of products including sensors prototypes, polyester-based SPE, bare SPE, carbon black modified SPE, gold SPE, SPE for chlorides in milk, and office paper-based SPE. It has applications for biomedical, materials, environmental, and defense fields.
- Mar 2024Grant (prize money)$351.3K
- Feb 2024Seed$549.1K
#6
Acquired · Verona, Veneto · founded 2011$1.9Mraised▾
Developer of fermentation technology to convert methane and carbon dioxide into useful chemicals. The company's consumer genomics services include personalized genome analysis for prediction of adverse drug response, clinical exome and whole-genome sequencing, Myocardial Infarction Risk assessment (MI Risk kit), high blood pressure, and cardiovascular disease risk assessment (Col Risk Kit) using genetic variants associated with the levels of LDL and HDL cholesterol and a non-invasive prenatal test (NIPT - Prenatal Insight).
- May 2022Grant (prize money)$263.6K
- Jan 2021Grant (prize money)$213.1K
- Jun 2016Grant (prize money)$391K
- Jan 2016Grant (prize money)$280.3K
#7
Funding Raised · Perugia, Umbria · founded 2010$1.8Mraised▾
Provider of products and services in the field of genomics, genetics, bioinformatics, and biology. Technology platforms include Illumina HiSeq1500, AB3500 genetic Analyser, Illumina MiSeq, Illumina MiSeqDx, Protein Microarray Platform which make Polo GGB a good facility for activities of Next-Gen Sequencing, bioinformatics analysis, and immunology. It offers sequencing, bioinformatics, and immunology services including SNPs and mutation discovery, genome assembly, transcriptome profiling, short read mapping, proteomics, etc.
- Feb 2022Grant (prize money)$12.1K
- Nov 2021Grant (prize money)$769.8K
- Feb 2017Grant (prize money)$876.3K
- Feb 2015Grant (prize money)$178.1K
#8
Seed · Verona, Veneto · founded 2016$996.5Kraised▾
Diamante has innovated the development of diagnostic kits for the detection of autoimmune diseases. It uses plants as bioreactors for the development of nanomaterials that can display multiple antigens by modified plant viruses. These viruses are cloned for sequence codifying for the peptide of interests and the resultant vector is used for Nicotiana benthamiana infection. The leaves of the plant become symptomatic and are further processed for purification of viral nanoparticles.
#9
Seed · Milan, Lombardy · founded 2017 · 9 employees$697.1Kraised▾
Provider of organs-on-chip platforms for preclinical studies. The company is pioneering the generation of predictive models of human organs and pathologies to test compound toxicity/functionality in a high-throughput fashion. The company organs portfolio comprises uBeat, a human heart-on-chip, and uKnee, a model of the human osteoarthritic joint.
- Oct 2022Seed$200K
- Jun 2022Grant (prize money)$79.8K
- Feb 2020Grant (prize money)$55K
- Dec 2019Grant (prize money)$55.1K
#10
Seed · Rome, Lazio · founded 2017 · 13 employees$1.8Mraised▾
Provider of genomic DNA tests for assessing predisposition to diseases & personalized nutrition. It offers a DNA test kit that is based on swab-based saliva sampling & provides online reports & nutritional plans. It has developed the platform for the COVID-19 HG Initiative to collect clinical data from hospitalized patients. It allows the computation of polygenic risk scores based on genetic variants.
- Mar 2021Seed$1.8M
- Jun 2020Grant (prize money)—
- Mar 2018Seed$61.7K
#11
Seed · Trento, Trentino South Tyrol · founded 2014 · 17 employees$509.2Kraised▾
Provider of tools for ribosome profiling. The company offers sequencing of short RNAs, RNA footprinting, ribosome profiling, and transcriptome analysis. It offers products such as molecules for monitoring protein synthesis, AHARIBO RNA for the analysis of translatome through the isolation of active ribosomes, AHARIBO protein for the analysis of synthesized proteins, micro and nanoparticles for biological applications, and library prep for ribosome profiling kit.
- Mar 2023Grant (prize money)$276.7K
- Dec 2020Grant (prize money)$315.7K
- Jun 2020Grant (prize money)—
- Nov 2016Seed$509.2K
#12
Funding Raised · Genoa, Liguria · founded 2021$868.9Kraised▾
Developer of platforms for prediction of drug and chemical toxicological outcomes. The platforms utilize patented laser-based technology, enabling simultaneous access to action potentials of cardiomyocytes. This technology facilitates electrophysiological measurements with high quality, parallelization, and reliability. The primary platform enables action potential recordings from cells for chronic cardiotoxicity assessment.
- Apr 2022Grant (prize money)$868.9K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences Platforms and Tools coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.